SEARCH

SEARCH BY CITATION

REFERENCES

  • Paradis NA, Martin GB, Rivers EP, et al. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmo-nary resuscitation. JAMA. 1990; 263:110613.
  • Lindner KH, Ahnefeld FW, Bawdler IM. Comparison of different doses of epinephrine on myocardial perfusion and resuscitation success during cardiopulmonary resuscitation in a pig model. Am J Emerg Med. 1991; 9:2731.
  • Paradis NA, Martin GB, Rosenberg J., Rivers EP, et al. The effect of standard and high dose epinephrine and coronary perfusion pressure during prolonged cardiopulmonary resuscitation. JAMA. 1991; 265:113944.
  • Callaham M., Madsen CD, Barton CW, Saunders CE, Pointer JP. A randomized clinical trial of high dose epinephrine and norepinephrine vs. standard-dose epinephrine in prehospital cardiac arrest. JAMA. 1992; 268:266772.
  • Brown CG, Martin DR, Pepe PE, et al. A comparison of standard-dose and high dose epinephrine in cardiac arrest outside the hospital. N Engl J Med. 1992; 327:10515.
  • Stiell IG, Hebert PC, Weitzman BW, et al. High-dose epinephrine in adult cardiac arrest. N Engl J Med. 1992; 327:104550.
  • Rivers EP, Rady MY, Martin GB, et al. Venous hyperoxia after cardiac arrest—characterization of a defect in systemic oxygen utilization. Chest. 1992; 102:178793.
  • Rivers EP, Wortsman J., Rady MY, et al. The effect of the total cumulative epinephrine dose administered during human CPR on he-modynamic, oxygen transport and utilization variables in the postre-suscitation period. Chest. 1994; 106:1499507.
  • Ditchey RV, Lindenfeld J. Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation. 1988; 78:3829.
  • Lindner KH, Ahnefeld F., Schuerrnan W., Bawdler IM. Epinephrine and norepinephrine in cardiopulmonary resuscitation—effects on myocardial oxygen delivery and consumption. Chest. 1990; 97:145862.
  • Abramson NS, Meisel A., Safar P. Deferred consent. A new approach for resuscitation research on comatose patients. JAMA. 1986; 255:246671.
  • Uretskt BF, Verbalis JG, Generalovich T., Valdes A., Reddy PS. Plasma vasopressin response to osmotic and hernodynamic stimuli in heart failure. Am J Physiol. 1985; 248:H396H402.
  • Shah SD, Clutter WE, Cryer PE. External and internal standards in the single-isotope derivative (radio enzymatic) measurement of plasma epinephrine and norepinephrine. J Lab Clin Med. 1985; 106:6249.
  • SAS Institute Inc. SASSTAT® User's Guide, 4th Ed, Volume 1. Cary, NC: SAS Institute Inc., 1989.
  • Tang WT, Weil MH, Shin S., et al. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation. 1995; 92:308993.
  • Berg RA, Otto CW, Kern KB, et al. High dose epinephrine results in greater early mortality after resuscitation from prolonged cardiac arrest in pigs: a prospective randomized study. Crit Care Med. 1994; 22:28290.
  • Livesay JJ, Follette DM, Fey KH, et al. Optimizing myocardial supply/demand balance with alpha-adrenergic drugs during cardiopulmonary resuscitation. J Thorac Cardiovasc Surg. 1978; 76:24451.
  • Gill GN. The hypothalamic-pituitary control system. In: SchwartzIL, RossJ.Jr, RapaportSI, et al. (eds). Physiological Basis of Medical Practice, 11th edition. Baltimore: Williams & Wilkins. 1985. pp 86779.
  • Anon. Pituitary. In: LituakK.. WelshOHJr. DouglasPM. SchnellNC, KesterL. (eds). AHHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1996. pp 23269.
  • Lindner KH, Prengel AW, Pfenninger EG, et al. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation. 1995; 91:21521.
  • Lindner KH, Brinkmann A., Pfenninger EG, et al. Effect of vasopressin on hemodynarnic variables. organ blood flow and acid base status in a pig model of cardiopulmonary resuscitation. Anesth Analg. 1993; 71:42735.
  • Prengel AW, Lindner KH, Keller A., Lurie KG. Cardiovascular function during the postresuscitation phase after cardiac arrest in pigs: a comparison of epinephrine versus vasopressin. Crit Care Med. 1996; 24:20149.
  • Lindner KH, Strohmenger HV, Ensinger H., et al. Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiol-ogy. 1992; 77:6628.
  • Paradis NA, Rose MI, Garg U. The effect of global ischemia and reperfusion on the plasma levels of vasoactive peptides. The neuroen-docrine response to cardiac arrest and resuscitation. Resuscitation. 1993; 26:2619.
  • Manning M., Stow S., Chan WY, Sawyer WH. Receptor-specific antagonists of vasopressin and oxytocin. Ann N Y Acad Sci. 1993; 68:21932.
  • Liard JF. Vasopressin in cardiovascular control: role of circulating vasopressin. Clin Sci. 1984; 67:47381.
  • Walker BR, Childs ME, Adams EM. Direct cardiac effects of vasopressin: role of V1 and V2 vasopressinergic receptors. Am J Physiol. 1988; 255:H260H265.
  • Michell RH, Kirk CJ, Billan MM. Hormonal stimulation of phos-phatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochem SOC Trans. 1979; 7:8614.
  • Thibonnier M., Bayer AL, Leng Z. Cytoplasmic and nuclear signaling pathways of VI-vascular vasopressin receptors. Regul Pept. 1993; 45:7984.
  • Goldberg JP, Schrier RW. Effect of calcium membrane blockers on in vivo vasoconstrictor properties of norepinephrine, angiotensin 11 and vasopressin. Miner Electrolyte Metab. 1984; 10:17883.
  • Penit J., Faure M., Serge J. Vasopressin and angiotensin I1 receptors in rat aortic smooth muscle cells in culture. Am J Physiol. 1983; 244:E72E82.
  • Ishikawa S., Goldberg JP, Schrier DM, et al. Interrelationship between subpressor effects of vasopressin and other vasoactive hormones in the rat. Miner Electrolyte Metab. 1984; 10:1849.
  • Wortsman J. The neuroendocrine response to global ischemia and reperfusion. In: ParadisNA, HalperinHR, NowakRM (eds). Cardiac Arrest, The Science and Practice of Resuscitation Medicine. Baltimore: Williams & Wilkins. 1996, pp 185204.
  • Paradis NA, Wortsman J., Malarkey W., et al. High atrial natriuretic peptide concentrations blunt the pressor response during cardiopulmo-nary resuscitation in humans. Crit Care Med. 1994; 22:2138.
  • Lapinski M., Stepniakowski K., Januzszewicz A., Noszczyk B., Szczepasska-Sadowsska E. Effect of vasopressin and VI receptor blockade on hypotensive action of ANP in normotensive and spontaneously hypertensive rats. J Physiol Pharmacol. 1992; 43:6578.
  • Lindner KH, Prengel AW, Brinkmann A., Strohmenger HU, Lindner IM, Lurie KG. Vasopressin administration in refractory cardiac arrest. Ann Intern Med. 1996; 124:10614.
  • Kerr JC, Reynolds DG, Swan KG. Vasopressin and blood Row to the canine small intestine. J Surg Res. 1978; 25:3541.
  • Katusic ZS, Shepherd JT, Vanhoutte DM. Vasopressin causes en-dothelium-dependent relaxations of the canine basilar artery. Circ Res. 1984; 55:5759.
  • Lambert M., de Peyer R., Muller AF. Reversible ischemic colitis after intravenous vasopressin therapy. JAMA. 1982; 247:6667.